Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: A multicenter, open-label, randomized, comparative trial

Neuropsychiatric Disease and Treatment

Volumn 4, Issue 3, 2008, Pages 675-686

  Thomas, Pierre ^a   Vieta, Eduard ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Amisulpride; Bipolar disorder; Clinical trial; Haloperidol; Mania; Valproate

Indexed keywords

AMISULPRIDE; ANTIPARKINSON AGENT; HALOPERIDOL; VALPROATE SEMISODIUM; VALPROIC ACID;

ADULT; AKATHISIA; AMENORRHEA; ANXIETY DISORDER; ARTICLE; BIPOLAR I DISORDER; BIPOLAR MANIA; BLOOD PRESSURE; BREAST CANCER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLYTIC HEPATITIS; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSKINESIA; EXTRAPYRAMIDAL SYNDROME; FATIGUE; FEMALE; FREQUENCY ANALYSIS; HEART RATE; HUMAN; HYPERSALIVATION; MAJOR CLINICAL STUDY; MALE; MANIA; MULTICENTER STUDY; OPEN STUDY; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REMISSION; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; TREMOR; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 47849104200     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: 10.2147/ndt.s3135     Document Type: Article

References (41)

1. Angst J, Angst F, Gerber-Werder R, et al. 2005. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up. Arch Suicide Res, 9:279-300.
2. [APA] American Psychiatric Association. 2002. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry, 159:1-50.
3. [APA] American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders. Washington DC: APA.
4. Barnes TR. 1989. A rating scale for drug-induced akathisia. Br J Psychiatry, 154:672-6.
5. Bowden CL. 2005. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder. J Clin Psychiatry, 66(Suppl 3):12-9.
6. Carta M, Zairo F, Mellino G, et al. 2006. An open label follow-up study on amisulpride in the add-on treatment of bipolar I patients. Clin Pract Epidemol Ment Health, 2:19.
7. Elgie R, Morselli PL. 2007. Social functioning in bipolar patients: the perception and perspective of patients, relatives and advocacy organizations - a review. Bipolar Disord, 9:144-57.
8. Endicott J, Spitzer RL, Fleiss JL, et al. 1976. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry, 33:766-71.
9. European Medicines Agency. 2007. Note for guidance on clinical investigation of medical products in the treatment and prevention of bipolar disorder.
10. Goodwin GM. 2003. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol, 17:149-73; discussion 147.
11. Grunze H, Kasper S, Goodwin G, et al. 2003. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry, 4:5-13.
12. [NIMH] National Institute of Mental Health. 1976. AIMS, Abnormal Involuntary Movement Scale. In Guy W (ed.). ECDEU Assessment Manual of Psychopharmacology Review. Rockville, USA: NIMH.
13. Krishnan KR. 2005. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med, 67:1-8.
14. Leucht S, Pitschel-Walz G, Engel RR, et al. 2002. Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials. Am J Psychiatry, 159:180-90.
15. Levin FR, Hennessy G. 2004. Bipolar disorder and substance abuse. Biol Psychiatry, 56:738-48.
16. Licht RW 2001. Limitations in randomised controlled trials evaluating drug effects in mania. Eur Arch Psychiatry Clin Neurosci, 251(Suppl 2): II66-71.
17. Licht RW. 2002. Limits of the applicability and generalizability of drug trials in mania. Bipolar Disord, 4(Suppl 1):66-8.
18. McIntyre RS, Brecher M, Paulsson B, et al. 2005. Quetiapine or haloperidol as monotherapy for bipolar mania - a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur Neuropsychopharmacol, 15:573-85.
19. Montgomery SA. 2002. Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders. Int Clin Psychopharmacol, 17(Suppl 4):S9-15; discussion S16-7.
20. Montgomery SA, Åsberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry, 134:382-9.
21. Muller-Oerlinghausen B, Retzow A, Henn FA, et al. 2000. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group. J Clin Psychopharmacol, 20:195-203.
22. Overall J, Gorham D. 1962. The Brief Psychiatric Rating Scale. Psychol Reports, 10:799-812.
23. Peuskens J, Moller HJ, Puech A. 2002. Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone. Eur Neuropsychopharmacol, 12:305-10.
24. Pini S, de Queiroz V, Pagnin D, et al. 2005. Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol, 15:425-34.
25. Rein W, Coulouvrat C, Dondey-Nouvel L. 2000. Safety profile of amisulpride in short- and long-term use. Acta Psychiatr Scand Suppl, 400:23-7.
26. Sachs G, Chengappa KN, Suppes T, et al. 2004. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord, 6: 213-23.
27. Sachs GS, Grossman F, Ghaemi SN, et al. 2002. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry, 159:1146-54.
28. Scherk H, Pajonk FG, Leucht S. 2007. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry, 64:442-55.
29. Segal J, Berk M, Brook S. 1998. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol, 21:176-80.
30. Shi L, Namjoshi MA, Zhang F, et al. 2002. Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. Int Clin Psychopharmacol, 17:227-37.
31. Simpson G, Angus J. 1970. A rating scale for extrapyramidal symptoms. Acta Psychiatr Scand, 45:11-19.
32. Smith LA, Cornelius V, Warnock A, et al. 2007. Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials. Bipolar Disord, 9:551-60.
33. Smulevich AB, Khanna S, Eerdekens M, et al. 2005. Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. Eur Neuropsychopharmacol, 15:75-84.
34. Spearing MK, Post RM, Leverich GS, et al. 1997. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res, 73:159-71.
35. Tohen M, Chengappa KN, Suppes T, et al. 2002. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry, 59:62-9.
36. Tohen M, Goldberg JF, Gonzalez-Pinto Arrillaga AM, et al. 2003. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch Gen Psychiatry, 60:1218-26.
37. Vieta E, Bourin M, Sanchez R, et al. 2005a. Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial. Br J Psychiatry, 187:235-42.
38. Vieta E, Carne X. 2005. The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate. Psychother Psychosomatics, 74:10-16.
39. Vieta E, Ros S, Goikolea JM, et al. 2005b. An open-label study of amisulpride in the treatment of mania. J Clin Psychiatry, 66:575-8.
40. Yatham LN, Paulsson B, Mullen J, et al. 2004. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol, 24:599-606.
41. Young RC, Biggs JT, Ziegler VE, et al. 1978. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry, 133:429-35.